Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.
about
B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB.Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer propertiesSynergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
P2860
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Synergistic activity of vorino ...... g cancers and hepatocarcinoma.
@en
Synergistic activity of vorino ...... g cancers and hepatocarcinoma.
@nl
type
label
Synergistic activity of vorino ...... g cancers and hepatocarcinoma.
@en
Synergistic activity of vorino ...... g cancers and hepatocarcinoma.
@nl
prefLabel
Synergistic activity of vorino ...... g cancers and hepatocarcinoma.
@en
Synergistic activity of vorino ...... g cancers and hepatocarcinoma.
@nl
P2093
P2860
P356
P1476
Synergistic activity of vorino ...... ng cancers and hepatocarcinoma
@en
P2093
Amandine Hurbin
Laetitia Vanwonterghem
Mehmet Ozturk
Murat Cokol
Sana Ferroudj
Sophie Michallet
Victor Jeannot
P2860
P304
P356
10.2147/OTT.S117743
P407
P577
2016-11-09T00:00:00Z